Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia

Endocrinology

Volumn 143, Issue 10, 2002, Pages 3955-3962

  Devlin, R D ^a   Du, Z ^b   Buccilli, V ^c   Jorgetti, V ^d   Canalis, E ^a,d  

^a St Francis Hospital   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; CORE BINDING FACTOR; OSTEOCALCIN; SOMATOMEDIN BINDING PROTEIN 5;

ANIMAL CELL; ARTICLE; BONE REMODELING; CELL FUNCTION; GENE OVEREXPRESSION; GLUCOSE HOMEOSTASIS; MITOGENICITY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOPENIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; STROMA CELL; TRABECULAR BONE; TRANSGENIC MOUSE;

ALKALINE PHOSPHATASE; ANIMALS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE REMODELING; GENE EXPRESSION; GENETIC MARKERS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, TRANSGENIC; OSTEOBLASTS; OSTEOCALCIN; STROMAL CELLS; TRANSGENES;

EID: 0036773550     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220129     Document Type: Article

References (38)

1. Margolis RN, Canalis E, Partridge NC 1996 Anabolic hormones in bone: Basic research and therapeutic potential. J Clin Endocrinol Metab 81:872-877
2. Hock JM, Centrella M, Canalis E 1988 Insulin-like growth factor I (IGF-I) has independent effects on bone matrix formation and cell replication. Endocrinology 122:254-260
3. Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue L-R, Malluche HH, Fagin JA, Clemens TL 2000 Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141:2674-2682
4. McCarthy T, Casinghino S, Centrella M, Canalis E 1994 Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: Regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors. J Cell Physiol 160:163-175
5. Okazaki R, Riggs BL, Conover CA 1994 Glucocorticoid regulation of insulin-like growth factor binding protein expression in normal human osteoblast-like cells. Endocrinology 134:126-132
6. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 16:3-34
7. Hwa V, Oh Y, Rosenfeld RG 1999 The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20:761-787
8. LaTour D, Mohan S, Linkhart TA, Baylink DJ, Strong DD 1990 Inhibitory insulin-like growth factor-binding protein: Cloning, complete sequence, and physiological regulation. Mol Endocrinol 4:1806-1814
9. Andress DL, Birnbaum RS 1992 Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 267:22467-22472
10. Franchimont N, Durant D, Canalis E 1997 Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures. Endocrinology 138:3380-3386
11. Franchimont N, Gangji V, Durant D, Canalis E 1997 Interleukin-6 with its soluble receptor enhances the expression of insulin-like growth factor I in osteoblasts. Endocrinology 138:5248-5255
12. Thrailkill KM, Quarles LD, Nagase H, Suzuki K, Serra DM, Fowlkes JL 1995 Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. Endocrinology 136:3527-3533
13. Nam TJ, Busby Jr WH, Clemmons DR 1996 Characterization and determination of the relative abundance of two types of insulin-like growth factor binding protein-5 proteases that are secreted by human fibroblasts. Endocrinology 137:5530-5536
14. Miyakoshi N, Richman C, Kasukawa Y, Linkhart TA, Baylink DJ, Mohan S 2001 Evidence that IGF-binding protein-5 functions as a growth factor. J Clin Invest 107:73-81
15. Nam T, Moralez A, Clemmons D 2002 Vitronectin binding to IGF binding protein-5 (IGFBP-5) alters IGFBP-5 modulation of IGF-I actions. Endocrinology 143:30-36
16. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G 1996 Increased bone formation in osteocalcin-deficient mice. Nature 382:448-452
17. Frenkel B, Capparelli C, Van Auken M, Baran D, Bryan J, Stein JL, Stein GS, Lian JL 1997 Activity of the osteocalcin promoter in skeletal sites of transgenic mice and during osteoblast differentiation in bone marrow-derived stromal cell cultures: Effects of age and sex. Endocrinology 138:2109-2116
18. Erlebacher A, Derynck R 1996 Increased expression of TGF-β2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 132:195-210
19. Shimasaki S, Shimonaka M, Zhang HP, Ling N 1991 Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem 266:10646-10653
20. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC 1994 Green fluorescent protein as a marker for gene expression. Science 263:802-805
21. Irwin N 1989 In: Sambrook J, Fritsch EF, Maniatis T, eds. Molecular Cloning. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 9.32-9.36
22. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
23. Nagy TR, Prince CW, Li J 2001 Validation of peripheral dual-energy x-ray absorptiometry for the measurement of bone mineral in intact and excised long bones of rats. J Bone Miner Res 16:1682-1687
24. Dobson KR, Reading L, Haberey M, Marine X, Scutt A 1999 Centrifugal isolation of bone marrow from bone: An improved method for recovery and quantitation of bone marrow osteoprogenitor cells from rat tibiae and femurae. Calcif Tissue Int 65:411-413
25. Chomczynski P, Sacchi N 1987 Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
26. Ogawa E, Maruyama M, Kagoshima H, Inuzuka M, Lu J, Satake M, Shigesada K, Ito Y 1993 PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AMLI gene. Proc Natl Acad Sci USA 90:6859-6863
27. Genovese C, Rowe D, Kream B 1984 Construction of DNA sequences complementary to rat α1 and α2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. Biochemistry 23:6210-6216
28. Lian J, Stewart C, Puchacz E, Mackowiak S, Shalhoub V, Collart D, Zambetti G, Stein G 1989 Structure of rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci USA 86:1143-1147
29. Feinberg AP, Vogelstein B 1984 A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 137:266-267
30. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 277:680-685
31. Gabbitas B, Pash JM, Delany AM, Canalis E 1996 Cortisol inhibits the synthesis of insulin-like growth factor-binding protein-5 in bone cell cultures by transcriptional mechanisms. J Biol Chem 271:9033-9038
32. Richman C, Baylink DJ, Lang K, Dony C, Mohan S 1999 Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology 140:4699-4705
33. Andress DL 2001 IGF-binding protein-5 stimulates osteoblast activity and bone accretion in ovariectomized mice. Am J Physiol 281:E283-E288
34. Rosen CJ, Dimai HP, Vereault D, Donahue LR, Beamer WG, Farley J, Linkhart S, Linkhart T, Mohan S, Baylink DJ 1997 Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone 21:217-223
35. Marcelli C, Yates AJ, Mundy GR 1990 In vivo effects of human recombinant transforming growth factor β on bone turnover in normal mice. J Bone Miner Res 5:1087-1096
36. Spinella-Jaegle S, Roman-Roman S, Faucheu C, Dunn F-W, Dawai S, Gallea S, Stiot V, Blanchet AM, Courtois B, Baron R, Rawadi G 2001 Opposite effects of bone morphogenetic protein-2 and transforming growth factor-β1 on osteoblast differentiation. Bone 29:323-330
37. Thomas T, Gori F, Spelsberg TC, Khosla S, Riggs BL, Conover CA 1999 Response of bipotential human marrow stromal cells to insulin-like growth factors: Effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes. Endocrinology 140:5036-5044
38. Miyakoshi N, Qin X, Kasukawa Y, Richman C, Srivastava AK, Baylink DJ, Mohan S 2001 Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism. Endocrinology 142:2641-2648